Related Experiment Video
Updated: Jan 13, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Acquired Reactive Perforating Collagenosis-A Rare Entity Occurring Within Common Disorders: A Systematic Review and
Maria Alexandra Junghetu1,2, Cristina Violeta Tutunaru3, Simona Laura Ianoși3
1Department of Oncologic Dermatology, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Acquired reactive perforating collagenosis (ARPC) is a rare skin condition often linked to systemic diseases. This review summarizes ARPC diagnosis, management, and highlights the need for clinical trials.
Area of Science:
- Dermatology
- Pathology
- Systemic Diseases
Background:
- Acquired reactive perforating collagenosis (ARPC) is a rare skin disorder.
- It commonly affects adults with comorbidities like diabetes, chronic kidney disease (CKD), cardiovascular issues, and cancers.
- Drug-induced and trauma-related cases are also documented.
Purpose of the Study:
- To systematically review current diagnostic and therapeutic strategies for ARPC.
- To provide updated insights into managing this rare condition.
- To report an associated case of ARPC with CKD.
Main Methods:
- Systematic literature review adhering to PRISMA 2020 guidelines.
- PubMed database search for open-access, primary human studies within the last 15 years.
- Inclusion of adult patients with histopathologically confirmed ARPC.
Main Results:
- Twenty-seven studies (case reports/series) were analyzed, with a mean patient age of 60.8 years.
- Most ARPC cases presented with comorbidities; drug-induced cases were also noted.
- Diagnostic clues include pruritic papules with central keratotic plugs, supported by dermoscopy, reflectance confocal microscopy, and mandatory histopathology showing transepidermal collagen elimination.
Conclusions:
- Diagnosis of ARPC necessitates a comprehensive workup for underlying systemic diseases, including malignancies.
- Current treatments encompass antihistamines, keratolytics, corticosteroids, retinoids, phototherapy, dupilumab, and allopurinol.
- Further clinical trials are required to establish optimal therapeutic protocols for ARPC.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pericarditis I: Introduction
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

